The fusion peptide demonstrated sleep-promoting effects, influenced neurotransmitter levels (5-HT, glutamate, dopamine, melatonin), and confirmed that the Tat cell-penetrating sequence was the more effective BBB carrier of two tested candidates establishing DSIP as a validated active scaffold for BBB-crossing fusion peptide sleep research and supporting the development of next-generation DSIP-based neuromodulatory tools

GLP-1 receptor agonists are a class of FDA-approved medications that mimic this hormone, producing three powerful effects: Appetite suppression signals your brain that youre full sooner and for longer Slowed gastric emptying food moves through your stomach more slowly, reducing hunger spikes Blood sugar regulation stimulates insulin release in response to meals, supporting metabolic health Originally developed for type 2 diabetes management, GLP-1 medications have since been FDA-approved specifically for chronic weight management in adults with obesity or overweight and related health conditions
So when the obesity process starts from energy surplus, all these systems are connected and feeding each other and it puts you in a really bad, vicious cycle and it only gets worse
Replenishment of GSH by its prodrugs treatment beneficially altered epigenetic enzymes, and VD-metabolism genes in hepatocytes
Deanfield J (2025)
There is a small cost applied to all NHS prescription deliveries